← Back to companies
Earli
0 open
South San Francisco, California, United StatesFounded 201838+ employees$59.9M raisedPrivate
Last round: series unknown · Aug 2024(5 rounds total)
Founded by Cyriac Roeding, David Suhy, Sanjiv Gambhir“Programmable genetic constructs expressed only in cancer cells for targeted tumor killing”
Backed by(26 investors)
Accenture VenturesAndreessen HorowitzKhosla VenturesMarc BenioffIKJ CapitalAlumni VenturesPerceptive AdvisorsJim BreyerShlomo Ben-HaimR. Martin ChavezRahul MehtaMenlo Ventures
Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. It's called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by Andreessen Horowitz's Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.
Open Positions at Earli (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Earli?
